Although there wasn’t marked difference of mRNA levels of SCAMP1, SCAMP3 and SCAMP4 between AML individuals and normal controls, the overall survival rates also showed negatively corelative with the expression of SCAMPs. The gene discussed is SCAMP4; the disease is acute myeloid leukemia.